The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis

Blood

Volumn 113, Issue 20, 2009, Pages 4942-4954

  Senis, Yotis A ^a   Tomlinson, Michael G ^a   Ellison, Stuart ^a   Mazharian, Alexandra ^a   Lim, Jenson ^a   Zhao, Yan ^a   Kornerup, Kristin N ^a   Auger, Jocelyn M ^a   Thomas, Steve G ^a   Dhanjal, Tarvinder ^a   Kalia, Neena ^a   Zhu, Jing W ^b   Weiss, Arthur ^b   Watson, Steve P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ALPHA2BBETA3 INTEGRIN; COLLAGEN; FIBRINOGEN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN VI; INTEGRIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE CD148; THROMBIN; UNCLASSIFIED DRUG; COLLAGEN RECEPTOR GLYCOPROTEIN VI, MOUSE; FC RECEPTOR; FIBRINOGEN RECEPTOR; MEMBRANE ANTIGEN; PTPRJ PROTEIN, MOUSE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMOSTASIS; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOGENESIS; TYROSINE BASED ACTIVATION MOTIF; ANIMAL; C57BL MOUSE; CELL ADHESION; CELL CULTURE; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS;

ANIMALS; ANTIGENS, SURFACE; BLOOD PLATELETS; CELL ADHESION; CELLS, CULTURED; FIBRINOGEN; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN TYROSINE PHOSPHATASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; RECEPTORS, IGG; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 66549093856     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-08-174318     Document Type: Article

References (66)

1. Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin αIIbβ3 signaling in platelets. J Thromb Haemost. 2005;3:1752-1762.
2. Woodside DG, Obergfell A, Talapatra A, Calderwood DA, Shattil SJ, Ginsberg MH. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains. J Biol Chem. 2002;277:39401-39408. (Pubitemid 35190914)
3. Abtahian F, Bezman N, Clemens R, et al. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol. 2006;26:6936-6949. (Pubitemid 44387642)
4. Mocsai A, Abram CL, Jakus Z, Hu Y, Lanier LL, Lowell CA. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat Immunol. 2006;7:1326-1333. (Pubitemid 46111254)
5. Ezumi Y, Shindoh K, Tsuji M, Takayama H. Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor γ-chain complex on human platelets. J Exp Med. 1998;188:267-276. (Pubitemid 28357755)
6. Suzuki-Inoue K, Tulasne D, Shen Y, et al. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem. 2002;277:21561-21566. (Pubitemid 34952302)
7. Obergfell A, Eto K, Mocsai A, et al. Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton. J Cell Biol. 2002;157:265-275. (Pubitemid 34839823)
8. Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, Shattil SJ. Src kinase activation by direct interaction with the integrin β cytoplasmic domain. Proc Natl Acad Sci U S A. 2003;100:13298-13302. (Pubitemid 37444736)
9. Arias-Salgado EG, Haj F, Dubois C, et al. PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol. 2005;170:837-845. (Pubitemid 41242115)
10. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell. 1999;3:629-638. (Pubitemid 29268446)
11. Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 1997;385:595-602. (Pubitemid 27087566)
12. Yamaguchi H, Hendrickson WA. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 1996;384:484-489.
13. Superti-Furga G, Fumagalli S, Koegl M, Courtneidge SA, Draetta G. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 1993;12:2625-2634. (Pubitemid 23218311)
14. Klages S, Adam D, Class K, Fargnoli J, Bolen JB, Penhallow RC. Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family. Proc Natl Acad Sci U S A. 1994;91:2597-2601. (Pubitemid 24139394)
15. Young MA, Gonfloni S, Superti-Furga G, Roux B, Kuriyan J. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell. 2001;105:115-126. (Pubitemid 32323921)
16. Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity. 2008;28:183-196.
17. McNeill L, Salmond RJ, Cooper JC, et al. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity. 2007;27:425-437. (Pubitemid 47418669)
18. Choudhuri K, Wiseman D, Brown MH, Gould K, van der Merwe PA. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature. 2005;436:578-582. (Pubitemid 41112933)
19. Lin J, Weiss A. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling. J Cell Biol. 2003;162:673-682. (Pubitemid 37022944)
20. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003;21:107-137. (Pubitemid 37174528)
21. Senis YA, Tomlinson MG, Garcia A, et al. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics. 2007;6:548-564. (Pubitemid 46554548)
22. Park SY, Ueda S, Ohno H, et al. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Invest. 1998;102:1229-1238. (Pubitemid 28436283)
23. Lin J, Zhu JW, Baker JE, Weiss A. Regulated expression of the receptor-like tyrosine phosphatase CD148 on hemopoietic cells. J Immunol. 2004;173:2324-2330. (Pubitemid 39063088)
24. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem J. 1995;306(pt 2):337-344.
25. Asselin J, Knight CG, Farndale RW, Barnes MJ, Watson SP. Monomeric (glycine-prolinehydroxyproline) 10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. Biochem J. 1999;339(pt 2):413-418. (Pubitemid 29209973)
26. Pearce AC, Senis YA, Billadeau DD, Turner M, Watson SP, Vigorito E. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J Biol Chem. 2004;279:53955-53962. (Pubitemid 40053126)
27. Best D, Senis YA, Jarvis GE, et al. GPVI levels in platelets: relationship to platelet function at high shear. Blood. 2003;102:2811-2818. (Pubitemid 37248851)
28. Wonerow P, Pearce AC, Vaux DJ, Watson SP. A critical role for phospholipase Cγ2 in αIIbβ3-mediated platelet spreading. J Biol Chem. 2003;278:37520-37529.
29. McCarty OJ, Larson MK, Auger JM, et al. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem. 2005;280:39474-39484.
30. Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J. 2005;19:825-827.
31. Dhanjal TS, Pendaries C, Ross EA, et al. A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood. 2007;109:4237-4244. (Pubitemid 46743388)
32. Kalia N, Auger JM, Atkinson B, Watson SP. Critical role of FcR γ-chain, LAT, PLCγ2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo. Microcirculation. 2008;15:325-335. (Pubitemid 351903347)
33. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood. 1996;88:907-914.
34. Snell DC, Schulte V, Jarvis GE, et al. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Biochem J. 2002;368:293-300. (Pubitemid 35463432)
35. Gibbins J, Asselin J, Farndale R, Barnes M, Law CL, Watson SP. Tyrosine phosphorylation of the Fc receptor γ-chain in collagen-stimulated platelets. J Biol Chem. 1996;271:18095-18099. (Pubitemid 26250797)
36. Poole A, Gibbins JM, Turner M, et al. The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341. (Pubitemid 27258634)
37. Quek LS, Pasquet JM, Hers I, et al. Fyn and Lyn phosphorylate the Fc receptor γ-chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood. 2000;96:4246-4253.
38. Dorahy DJ, Berndt MC, Burns GF. Capture by chemical crosslinkers provides evidence that integrin αIIbβ3 forms a complex with protein tyrosine kinases in intact platelets. Biochem J. 1995;309(pt 2):481-490.
39. Kralisz U, Cierniewski CS. Association of pp60c-src with αIIbβ3 in resting platelets. Biochem Mol Biol Int. 1998;45:735-743. (Pubitemid 28393541)
40. Le Pera I, Iuliano R, Florio T, et al. The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene. 2005;24:3187-3195. (Pubitemid 40695087)
41. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10:64-71. (Pubitemid 38524700)
42. Kato K, Kanaji T, Russell S, et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102:1701-1707. (Pubitemid 37022563)
43. Cheli Y, Jensen D, Marchese P, et al. The modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice. Blood. 2008;111:1266-1273. (Pubitemid 351213409)
44. Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood. 2006;107:3902-3906. (Pubitemid 43076376)
45. Vandendries ER, Hamilton JR, Coughlin SR, Furie B, Furie BC. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A. 2007;104:288-292. (Pubitemid 46068024)
46. Mangin P, Yap CL, Nonne C, et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency. Blood. 2006;107:4346-4353. (Pubitemid 43801360)
47. Nonne C, Lenain N, Hechler B, et al. Importance of platelet phospholipase Cγ2 signaling in arterial thrombosis as a function of lesion severity. Arterioscler Thromb Vasc Biol. 2005;25:1293-1298. (Pubitemid 40776624)
48. Harper MT, Sage SO. PAR-1-dependent pp60src activation is dependent on protein kinase C and increased [Ca2+]: evidence that pp60src does not regulate PAR-1-dependent Ca2+ entry in human platelets. J Thromb Haemost. 2006;4:2695-2703.
49. Minuz P, Fumagalli L, Gaino S, et al. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets. Biochem J. 2006;400:127-134. (Pubitemid 44763827)
50. Moarefi I, LaFevre-Bernt M, Sicheri F, et al. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 1997;385:650-653. (Pubitemid 27087580)
51. Liu X, Brodeur SR, Gish G, et al. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene. 1993;8:1119-1126. (Pubitemid 23129833)
52. Palka HL, Park M, Tonks NK. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem. 2003;278:5728-5735. (Pubitemid 36800817)
53. Kovalenko M, Denner K, Sandstrom J, et al. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J Biol Chem. 2000;275:16219-16226. (Pubitemid 30366934)
54. Holsinger LJ, Ward K, Duffield B, Zachwieja J, Jallal B. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). Oncogene. 2002;21:7067-7076. (Pubitemid 35252981)
55. Baker JE, Majeti R, Tangye SG, Weiss A. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation. Mol Cell Biol. 2001;21:2393-2403. (Pubitemid 32222092)
56. Tsuboi N, Utsunomiya T, Roberts RL, et al. The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J. 2008;413:193-200. (Pubitemid 351946875)
57. Gibbins JM, Briddon S, Shutes A, et al. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor γ-chain and linker for activitor of T cells (LAT) in platelets stimulated by collagen and convulxin. J Biol Chem. 1998;273:34437-34443. (Pubitemid 29008923)
58. Pasquet JM, Gross B, Quek L, et al. LAT is required for tyrosine phosphorylation of phospholipase cγ2 and platelet activation by the collagen receptor GPVI. Mol Cell Biol. 1999;19:8326-8334. (Pubitemid 30414026)
59. Suzuki-Inoue K, Inoue O, Frampton J, Watson SP. Murine GPVI stimulates weak integrin activation in PLCγ2-/- platelets: involvement of PLCγ1 and PI3-kinase. Blood. 2003;102:1367-1373. (Pubitemid 36988045)
60. Watanabe N, Nakajima H, Suzuki H, et al. Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. Blood. 2003;102:541-548. (Pubitemid 36841973)
61. Pasquet JM, Bobe R, Gross B, et al. A collagen-related peptide regulates phospholipase Cγ2 via phosphatidylinositol 3-kinase in human platelets. Biochem J. 1999;342(pt 1):171-177. (Pubitemid 29410863)
62. Somani AK, Bignon JS, Mills GB, Siminovitch KA, Branch DR. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem. 1997;272:21113-21119.
63. Pasquet JM, Quek L, Pasquet S, et al. Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI. J Biol Chem. 2000;275:28526-28531. (Pubitemid 30704182)
64. Best D, Pasquet S, Littlewood TJ, Brunskill SJ, Pallister CJ, Watson SP. Platelet activation via the collagen receptor GPVI is not altered in platelets from chronic myeloid leukaemia patients despite the presence of the constitutively phosphorylated adapter protein CrkL. Br J Haematol. 2001;112:609-615. (Pubitemid 32222830)
65. Zhang ZY. Mechanistic studies on protein tyrosine phosphatases. Prog Nucleic Acid Res Mol Biol. 2003;73:171-220. (Pubitemid 137639543)
66. Sorby M, Sandstrom J, Ostman A. An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1. Oncogene. 2001;20:5219-5224. (Pubitemid 32844052)